Australia markets close in 1 hour 57 minutes

Tiziana Life Sciences Ltd (TLSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.7028-0.0422 (-5.66%)
At close: 04:00PM EDT
0.7071 +0.00 (+0.61%)
After hours: 06:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 70.50M
Enterprise value 64.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.30
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.31

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-5.06%
S&P500 52-week change 324.49%
52-week high 31.2700
52-week low 30.4100
50-day moving average 30.5360
200-day moving average 30.6084

Share statistics

Avg vol (3-month) 3185.99k
Avg vol (10-day) 3524.26k
Shares outstanding 5100.31M
Implied shares outstanding 6106.33M
Float 861.41M
% held by insiders 138.03%
% held by institutions 10.78%
Shares short (15 Apr 2024) 4257.78k
Short ratio (15 Apr 2024) 44.98
Short % of float (15 Apr 2024) 40.42%
Short % of shares outstanding (15 Apr 2024) 40.26%
Shares short (prior month 15 Mar 2024) 4365.78k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22499:1000
Last split date 331 July 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.64%
Return on equity (ttm)-90.40%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.77M
Net income avi to common (ttm)-19.5M
Diluted EPS (ttm)-0.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.6M
Total cash per share (mrq)0.07
Total debt (mrq)353k
Total debt/equity (mrq)2.66%
Current ratio (mrq)3.85
Book value per share (mrq)0.13

Cash flow statement

Operating cash flow (ttm)-19.09M
Levered free cash flow (ttm)-10.88M